About STAT Diagnostica
STAT Diagnostica is a company based in Barcelona (Spain) founded in 2010. STAT Diagnostica has raised $53.66 million across 4 funding rounds from investors including Idinvest Partners, Kurma Partners and Official Credit Institute. STAT Diagnostica operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Barcelona, Spain
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$53.66 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Idinvest Partners
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of STAT Diagnostica
STAT Diagnostica has successfully raised a total of $53.66M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in STAT Diagnostica
STAT Diagnostica has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Idinvest Partners, Kurma Partners and Official Credit Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture investments in systems, infrastructure, and applications for enterprise founders.
|
Locked | Locked | Locked | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Locked | Locked | Locked | |
|
Biotech startups are funded through venture capital in life sciences.
|
Locked | Locked | Locked |
Investor details for STAT Diagnostica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by STAT Diagnostica
Investment portfolio details for STAT Diagnostica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - STAT Diagnostica
Detailed financials for STAT Diagnostica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stat Diagnostica Comparisons
Peer comparison for STAT Diagnostica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of STAT Diagnostica
STAT Diagnostica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of STAT Diagnostica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stat Diagnostica
Complete news archive for STAT Diagnostica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about STAT Diagnostica
STAT Diagnostica was founded in 2010 and raised its 1st funding round 1 year after it was founded.
STAT Diagnostica is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
STAT Diagnostica is a funded company, having raised a total of $53.66M across 4 funding rounds to date.
Provider of a diagnostic platform for molecular diagnostics and immunoassays. The proprietary DiagCore comprises an Analyzer that runs on consumable DiagCore cartridges. The STAT-Molecular cartridge automates sample homogenization, cell disruption, nucleic acid purification and delivers up to 50-plex target detection employing qPCR. This test cartridge is designed to automate molecular assays in the fields of infectious diseases, oncology, coagulation, prenatal, inherited diseases, or companion diagnostics. It offers test cartridges designed to automate immunoassays for critical care markers such as Procalcitonin (Sepsis), Troponin (AMI), Ngal (AKI), C-reactive protein (Inflammation), hCG (pregnancy), among others.
STAT Diagnostica's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
STAT Diagnostica has 9 investors. Key investors include Idinvest Partners, Kurma Partners, Official Credit Institute, Next47, and Gilde Healthcare.